6130401L20Rik Activators
Chemical activators of EGF-like and EMI domain containing 1 can engage in a variety of biochemical interactions that lead to the activation of this protein. Genistein, for instance, is known for its ability to inhibit tyrosine kinase but at specific concentrations, it can enhance this enzyme's activity. This increase in activity can trigger the activation of the EGFR, which is associated with the EGF-like and EMI domain containing 1 protein, initiating a cascade of intracellular signaling events. Similarly, quercetin, a flavonoid antioxidant, can upregulate kinase activity, leading to phosphorylation events within the EGFR signaling pathways. This activity promotes the activation cascade involving EGF-like and EMI domain containing 1. Sphingosine-1-phosphate, acting through G protein-coupled receptors, and forskolin, which directly activates adenylyl cyclase, both result in the activation of cascades that can intersect with EGFR signaling pathways, thereby influencing the state of EGF-like and EMI domain containing 1.
Additionally, compounds like dibutyryl-cAMP and calcium ionophore A23187 elevate intracellular levels of cAMP and calcium, respectively, which in turn activate protein kinase A (PKA) and calcium-dependent kinases. These kinases are capable of phosphorylating components within the EGFR signaling pathway, which includes EGF-like and EMI domain containing 1. Moreover, zinc can act as a cofactor for enzymes that release EGFR ligands, thereby facilitating EGFR activation. Thapsigargin, by raising intracellular calcium levels, indirectly influences the activation of calcium-dependent kinases, which can converge on the EGFR signaling pathway. Through these diverse but interconnected biochemical routes, each of these chemicals can initiate a series of events leading to the activation of EGF-like and EMI domain containing 1, demonstrating the intricate web of interactions that regulate protein function within cellular environments.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that at certain concentrations can paradoxically enhance tyrosine kinase activity. This enhancement can lead to the activation of EGFR and downstream signaling pathways, potentially resulting in the activation of EGF-like and EMI domain containing 1. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid with antioxidant properties, can upregulate kinase activity leading to the phosphorylation and activation of signaling pathways connected to EGFR, thus potentially activating EGF-like and EMI domain containing 1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate, acting through its G protein-coupled receptors, can activate signaling pathways that converge with EGFR signaling, potentially leading to the activation of EGF-like and EMI domain containing 1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then activate signaling pathways that intersect with EGFR signaling, potentially leading to the activation of EGF-like and EMI domain containing 1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that, in certain contexts, can result in a compensatory overactivation of upstream EGFR signaling, potentially leading to the activation of proteins associated with EGFR, including EGF-like and EMI domain containing 1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to the compensatory activation of the MAPK/ERK pathway, which is downstream of EGFR, thus potentially activating EGF-like and EMI domain containing 1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can enhance the differentiation of epithelial cells, leading to increased EGFR signaling activity, which could result in the activation of EGF-like and EMI domain containing 1 through the EGFR signaling pathway. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
Eicosapentaenoic acid can alter cell membrane fluidity and receptor conformation, potentially enhancing the activation of EGFR and its downstream signaling pathways, which could lead to the activation of EGF-like and EMI domain containing 1. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc can serve as a cofactor for metalloproteinases that release membrane-tethered EGFR ligands, leading to EGFR activation and potentially the activation of downstream proteins including EGF-like and EMI domain containing 1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore A23187 increases intracellular calcium levels, which can activate calcium-dependent kinases that phosphorylate and activate EGFR, potentially leading to the activation of EGF-like and EMI domain containing 1. | ||||||